Showing 3191-3200 of 10546 results for "".
Current Unmet Needs in Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/current-unmet-needs-in-plaque-psoriasis/20098/Patrick Burnett, Chief Medical Officer of Arcutis Biotherapeutics, discusses new insights from a national survey on the psychosocial impact of plaque psoriasis and the current unmet need for topical therapies for plaque psoriasis. These data reinforce that psychosocial wellbeing can be just as imporMeaningful Innovation in Medical Dermatology at Arcutis Biotherapeutics
https://practicaldermatology.com/topics/psoriasis/meaningful-innovation-in-medical-dermatology-at-arcutis-biotherapeutics/20099/Frank Watanabe, President and CEO of Arcutis Biotherapeutics, shares what “meaningful innovation” means to Arcutis and how the company aims to create meaningful change for people living with chronic skin conditions.What people want and why it matters
https://practicaldermatology.com/topics/general-topics/what-people-want-and-why-it-matters/19526/Our patients differ in both their skin biology and their use of skin care products on a daily basis. Discover how understanding the behaviors and practices of men and women can allow better and more effective product recommendations.Avoid the Three Most Common Asset Protection Mistakes
https://practicaldermatology.com/topics/practice-management/avoid-the-three-most-common-asset-protection-mistakes/18368/OJM Group principal David Mandell, JD, MBA discusses the importance of protecting personal and business assets from lawsuits, and outlines strategies to avoid the three asset protection mistakes made by most doctors. Click here to request or download a free copy of Wealth Protection Planning for DePatient Outreach Initiatives; Erelzi Approved
https://practicaldermatology.com/topics/practice-management/dermwiretv-patient-outreach-initiatives-erelzi-approved---etudruli/18580/DermatologistOnCall® Partners with NPF to enhance access to care for psoriasis. Vivacare Partners with NRS for patient education. Erelzi from Sandoz approved as biosimilar to Enbrel. And the FDA bans antibacterial ingredients from hand soaps; Calls for plain soap and water hand washing.M22™ with ResurFX™ - A User's Perspective
https://practicaldermatology.com/topics/general-topics/m22-with-resurfx-a-user-s-perspective/18803/Dr. Palm shares her perspective on the M22 IPL system with non-ablative one-pass resurfacing, and why it is one of the most popular procedures in her clinic.Guys, Don't Be Like Paul:Â PSA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/guys-don-t-be-like-paul-psa/18924/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The first PSA and video focuses specifically on men and features Dr. Keaney. Data from the Skin Cancer Foundation cited by ASDS show that only 30 percent of American men areBiologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/Notable Case Report: Intralesional Kenalog Injections for Chemotherapy-Induced Alopecia; Ask An Expert: Hair Loss
https://practicaldermatology.com/youngmd-connect/resident-resource-center/notable-case-report-intralesional-kenalog-injections-for-chemotherapy-induced-alopecia-ask-an-expert-hair-loss/21052/Emollient-Based Therapy for AD: A Potential Role for Rebalancing the Microbiome
https://practicaldermatology.com/issues/supplements/emollient-based-therapy-for-ad-a-potential-role-for-rebalancing-the-microbiome/23136/